AnalystsCharles ZhouCharles Zhou's Stock Forecasts
AnalystsCharles Zhou
Analyst Ranking
Top 33%
#1644 out of 5100 analysts
Average Return
+35.03%
Win Rate
71%5 out of 7
Risk vs Reward
Poor
Good
Charles Zhou's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cogent Biosciences IncCOGT | +186.26% | $11.79 | $33.75 | 2025-08-24 - 2025-11-17 | Strong Buy |
Futu Holdings LtdFUTU | +56.53% | $51.51 | $80.63 | 2024-01-04 - 2025-01-03 | Strong Buy |
Futu Holdings LtdFUTU | +43.94% | $117.11 | $168.57 | 2025-03-16 - 2025-11-17 | Strong Buy |
Zymeworks IncZYME | +43.00% | $8.00 | $11.44 | 2023-03-07 - 2024-03-07 | Strong Buy |
Cogent Biosciences IncCOGT | +30.11% | $8.90 | $11.58 | 2022-06-27 - 2023-06-26 | Strong Buy |
Charles Zhou Analyst Color
Get additional color on Charles Zhou's coverage of popular stocks
Charles Zhou's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cogent Biosciences IncCOGT | 2 | Strong Buy | $20.00 | -40.74% | Maintains | 3 months ago |
Futu Holdings LtdFUTU | 3 | Strong Buy | $136.00 | -19.32% | Maintains | 8 months ago |
Zymeworks IncZYME | 1 | Strong Buy | $16.00 | N/A | Reiterates | 3 years ago |
Macrogenics IncMGNX | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Pmv Pharmaceuticals IncPMVP | 1 | Strong Buy | $56.00 | N/A | Initiates Coverage On | 4 years ago |
Repare Therapeutics IncRPTX | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 4 years ago |
Qudian IncQD | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
China Life Insurance Co LtdLFCHY | 1 | Hold | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.